[Pulmonary surfactants].
D000142:Acidosis, Respiratory / Q000503:physiopathology; D000777:Anesthetics / Q000009:adverse effects; D055592:Biophysical Phenomena; D001703:Biophysics; D004548:Elasticity; D005112:Extracorporeal Circulation / Q000009:adverse effects; D006801:Humans; D006819:Hyaline Membrane Disease / Q000503:physiopathology; D007231:Infant, Newborn; D008168:Lung / Q000378:metabolism / Q000502:physiology* / Q000503:physiopathology; D008170:Lung Compliance; D010100:Oxygen / Q000506:poisoning; D011024:Pneumonia, Viral / Q000150:complications / Q000503:physiopathology; D011041:Poisoning / Q000503:physiopathology; D011650:Pulmonary Alveoli / Q000378:metabolism / Q000502:physiology; D011654:Pulmonary Edema / Q000503:physiopathology; D012127:Respiratory Distress Syndrome, Newborn / Q000503:physiopathology; D013500:Surface Tension; D013501:Surface-Active Agents / Q000096:biosynthesis; D014628:Vagotomy / Q000009:adverse effects
D000777:Anesthetics; D013501:Surface-Active Agents; D010100:Oxygen
Plicní surfaktant.